By Drug Target Review2025-10-13T13:31:55
Scientists have discovered a rare type of brain cell that appears to drive the chronic inflammation seen in progressive multiple sclerosis – which could potentially lead to new disease-modifying therapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-26T13:22:42
Sponsored by bit.bio
2024-02-02T15:48:26
Sponsored by Bio-Techne
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2023-02-07T15:25:20
Sponsored by Bio-Techne
2024-01-10T08:23:16
Sponsored by BellBrook Labs
Site powered by Webvision Cloud